Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Optic neuritis and the risk of multiple sclerosis—what can we learn from a brain MRI scan?

Abstract

In the Optic Neuritis Study Group's 15-year final follow-up, the cumulative probability for developing multiple sclerosis (MS) after a first episode of optic neuritis was 50%, with the risk highest in the first 5 years. If the MRI was negative at baseline, the risk of MS was 25% overall, and much lower for males and those with atypical presentations of optic neuritis. A single lesion doubled the 15-year risk to 50%. The risk associated with three or more lesions was 78%. However, the conclusion that “even a single lesion more than doubles the future risk of MS” must be interpreted with caution when using the latest imaging technology—the baseline MRI scans in this study were performed before availability of gadolinium enhancement and advanced inversion recovery imaging. The 32% conversion rate to MS between years 10 and 15 for patients with a positive baseline scan suggests that patients should be followed up for longer in order to further define the natural history of the disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Optic Neuritis Study Group (2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65: 727–732

  2. Beck RW et al. (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 329: 1764–1769

    Article  CAS  Google Scholar 

  3. McDonald WI et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50: 121–127

    Article  CAS  Google Scholar 

  4. Geurts JJ et al. (2005) Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 236: 254–260

    Article  Google Scholar 

  5. Jacobs LD et al. (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 343: 898–904

    Article  CAS  Google Scholar 

  6. Comi G et al. (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study. Lancet 357: 1576–1582

    Article  CAS  Google Scholar 

  7. Rizzo JF III and Lessell S (1988) Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology 38: 185–190

    Article  Google Scholar 

  8. Ghezzi A et al. (1999) Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J Neurol 246: 770–775

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This article was support by an unrestricted grant from Research to Prevent Blindness.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feldon, S. Optic neuritis and the risk of multiple sclerosis—what can we learn from a brain MRI scan?. Nat Rev Neurol 4, 532–533 (2008). https://doi.org/10.1038/ncpneuro0911

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0911

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing